Ann Gen Psychiatry

1. DING Y, Wang J, Luo Q, Deng C, et al
   Shared genetic architecture between schizophrenia and gastrointestinal diseases: insights from large-scale genome-wide cross-trait analysis.
   Ann Gen Psychiatry. 2026 Jan 28. doi: 10.1186/s12991-025-00625.
   

   >> Share

   
   

   
   BMC Gastroenterol

2. ZHAO Y, Zhang Y, Gao Z, Yuan X, et al
   Effect of combined continuity care guided by Orem's self-care model and low FODMAP diet on gut microbiota composition and symptoms in patients with irritable bowel syndrome.
   BMC Gastroenterol. 2026 Jan 28. doi: 10.1186/s12876-026-04621.
   

   >> Share

   
   

   
   Clin Gastroenterol Hepatol

3. VERMEIJDEN NK, van der Feen C, Groeneweg M, Hummel T, et al
   Peppermint oil and sweets in pediatric irritable bowel syndrome and functional abdominal pain: a randomized trial.
   Clin Gastroenterol Hepatol. 2026 Jan 27:S1542-3565(26)00042.
   

   >> Share

   
   

   
   Clin Rheumatol

4. HUGHES M, Jude E, McMahan ZH, Alam U, et al
   An epidemiological study estimating the burden of cancer risk in patients with Raynaud's phenomenon.
   Clin Rheumatol. 2026 Jan 29. doi: 10.1007/s10067-026-07961.
   

   >> Share

   
   

   
   Diagnostics (Basel)

5. LUNDERVOLD A, Billing J, Berentsen B, Lundervold AJ, et al
   Patient Similarity Networks for Irritable Bowel Syndrome: Revisiting Brain Morphometry and Cognitive Features.
   Diagnostics (Basel). 2026;16:357.
   

   >> Share

   
   

   
   Dig Dis Sci

6. MCSHANE C, O'Connell F, Kevans D, O'Sullivan J, et al
   Ex Vivo Human Colonic Explants Identify Metabolic Alterations and Cytokine Dysregulation in Ulcerative Colitis: A Pilot Study.
   Dig Dis Sci. 2026 Jan 26. doi: 10.1007/s10620-025-09665.
   

   >> Share

   
   

   
   Eur J Gastroenterol Hepatol

7. AKRAM U, Ul Ain H, Ahmed S, Fatima E, et al
   Efficacy and tolerability of plecanatide for irritable bowel syndrome with constipation and chronic idiopathic constipation: a systematic review and meta-analysis.
   Eur J Gastroenterol Hepatol. 2026 Jan 13. doi: 10.1097/MEG.0000000000003115.
   

   >> Share

   
   

   
   Folia Med Cracov

8. JANOWSKI WM, Kaczmarczyk GM, Tarasiuk-Zawadzka A, Fichna J, et al
   Therapeutic strategies in irritable bowel syndrome: current standards, emerging options and future challenges.
   Folia Med Cracov. 2025;65:5-29.
   

   >> Share

   
   

   
   Front Cardiovasc Med

9. SMITH SJ, Sichlau MJ, Rowe PC, Knight DRT, et al
   Case Report: Neuropsychiatric improvement after treatment of pelvic venous disorder in a multisyndromic patient.
   Front Cardiovasc Med. 2026;12:1574432.
   

   >> Share

   
   

   
   Gastroenterol Clin North Am

10. GUAN M, Chang L
    Biomarkers in Irritable Bowel Syndrome: Rationale and Practical Use.
    Gastroenterol Clin North Am. 2026;55:91-105.
    

    >> Share

    
    

    
    Gut

11. MARASCO G, Schmulson M, Ghoshal UC, Khatun R, et al
    Post-infection disorders of gut-brain interaction: results of the Rome Foundation Global Epidemiology Study.
    Gut. 2026 Jan 29:gutjnl-2025-336509. doi: 10.1136/gutjnl-2025-336509.
    

    >> Share

    
    

    
    Gut Liver

12. SONG CH, Kim N, Nam RH, Choi H, et al
    Sex-Dependent Microbial and Host Profiles Following Fecal Microbiota and Bifidobacterium longum Treatment in Stress-Induced Gut Dysbiosis.
    Gut Liver. 2026 Jan 28. doi: 10.5009/gnl250440.
    

    >> Share

    
    

    
    Gut Microbes

13. HOU S, Ning T, Liu S, Yang X, et al
    Fusobacterium nucleatum plays a pathogenic role in a murine model of irritable bowel syndrome by modulating intestinal purine metabolism and promoting mast cell activation.
    Gut Microbes. 2026;18:2620124.
    

    >> Share

    
    

    
    Indian J Dermatol

14. KOCA TT, Gogebakan H, Nazik H, Cetin G, et al
    Clinical Importance of Central Sensitization and Neuropathic Pain in The Treatment and Follow-Up of Patients with Psoriasis and Psoriatic Arthritis.
    Indian J Dermatol. 2026;71:58-64.
    

    >> Share

    
    

    
    Infect Disord Drug Targets

15. RAMEZANI A, Yazdanmanesh M, Heidari H, Khadiv A, et al
    Phenotypic and Genotypic Characterization of ESBL- and Carbapenemase-producing Escherichia coli Isolates in Irritable Bowel Syndrome (IBS) Patients.
    Infect Disord Drug Targets. 2026.
    

    >> Share

    
    

    
    Int J Mol Sci

16. ZHU Z, Liu Z, He Y, He X, et al
    G Protein-Coupled Receptors in Irritable Bowel Syndrome: Mechanisms and Therapeutic Opportunities.
    Int J Mol Sci. 2026;27:752.
    

    >> Share

    
    
17. JIA SM, Wang KQ, Hu SF, Weng RX, et al
    A Glutamatergic Medial Prefrontal Cortex-Locus Coeruleus Circuit Drives Intestinal Dysmotility in Diarrhea-Predominant Irritable Bowel Syndrome.
    Int J Mol Sci. 2026;27:681.
    

    >> Share

    
    

    
    J Agric Food Chem

18. KOU RW, Zhang RJ, Xia B, Bai GY, et al
    Ganoderic Acid A Modulates Enteric Neurons and Intestinal Homeostasis in Irritable Bowel Syndrome by Microbiota Sensing.
    J Agric Food Chem. 2026 Jan 28. doi: 10.1021/acs.jafc.5c15628.
    

    >> Share

    
    

    
    J Clin Gastroenterol

19. BRINDICCI VF, Cristofori F, Franceschini S, Gnasso I, et al
    Self-reported Nonceliac Gluten Sensitivity in Patients With Irritable Bowel Syndrome: A Cross-sectional Analysis.
    J Clin Gastroenterol. 2026 Jan 30. doi: 10.1097/MCG.0000000000002306.
    

    >> Share

    
    

    
    J Clin Med

20. LIM YH, Yoo JH, Park JW, Hwang JM, et al
    Gastrointestinal Diagnostic Coding After Spinal Cord Injury: Health Behavior Correlates and Implications for Neurogenic Bowel Management in a Nationwide Claim-Based Cohort.
    J Clin Med. 2026;15:760.
    

    >> Share

    
    
21. SACCO R, Facciorusso A, Giannini E, Bellini M, et al
    Revisiting Abdominal Pain in IBS: From Pathophysiology to Targeted Management with Alverine Citrate/Simeticone.
    J Clin Med. 2026;15:722.
    

    >> Share

    
    

    
    J Microbiol Biotechnol

22. KIM Y, Lee MH, Seo SH, Pak J, et al
    Integrated Metabolomics and Microbial Profiling in Patients with Irritable Bowel Syndrome.
    J Microbiol Biotechnol. 2026;36:e2511041.
    

    >> Share

    
    

    
    J Public Health (Oxf)

23. BAI W, Zheng Y, Lin S, Pan Y, et al
    Child maltreatment and its association with incident irritable bowel syndrome: genetic risk and mediation pathways in the UK biobank.
    J Public Health (Oxf). 2026 Jan 30:fdag004. doi: 10.1093.
    

    >> Share

    
    

    
    Medicina (Kaunas)

24. ALMALKI AS, Jaafari NY, Aldossari NG, Alharbi AA, et al
    Efficacy of Specific Probiotic Strains in Subtypes of Irritable Bowel Syndrome: Systematic Review and Meta-Analysis of Randomized Controlled Trials.
    Medicina (Kaunas). 2025;62:89.
    

    >> Share

    
    

    
    Microorganisms

25. PICCIRILLO M, Renzi E, De Vito C, Mennini M, et al
    Efficacy and Safety of Probiotics in Children with Irritable Bowel Syndrome: A Systematic Review and Meta-Analysis.
    Microorganisms. 2025;14:23.
    

    >> Share

    
    

    
    Neurogastroenterol Motil

26. GHOSHAL UC, Singh R, Goenka MK
    Post-Coronavirus Disease (COVID)-19 Irritable Bowel Syndrome: What We've Learned So Far.
    Neurogastroenterol Motil. 2026;38:e70250.
    

    >> Share

    
    
27. PIA F, Decraecker L, Looze D, Hirsch D, et al
    Dose-Dependent Effect of the Histamine 1 Receptor Antagonist Ebastine in Patients With Non-Constipated Irritable Bowel Syndrome.
    Neurogastroenterol Motil. 2026;38:e70242.
    

    >> Share

    
    
28. ACCARIE A, Huyghe P, Meleine M, Van den Houte K, et al
    Oral Local Budesonide Treatment Ameliorates Immune Activation and Colonic Sensitivity in a Spontaneous Model for Disorders of Gut-Brain Interaction.
    Neurogastroenterol Motil. 2026;38:e70233.
    

    >> Share

    
    

    
    Nutr Rev

29. HERNANDO A, Morais Costa B, Charneca S, Santos I, et al
    Mapping the Evidence on IgG-Based Elimination Diets for the Management of Irritable Bowel Syndrome in Adults: A Systematic Scoping Review.
    Nutr Rev. 2026 Jan 24:nuaf268. doi: 10.1093.
    

    >> Share

    
    

    
    Nutrients

30. PASTRAS P, Aggeletopoulou I, Bali M, Triantos C, et al
    Plant-Derived Treatments for IBS: Clinical Outcomes, Mechanistic Insights, and Their Position in International Guidelines.
    Nutrients. 2026;18:183.
    

    >> Share

    
    

    
    Therap Adv Gastroenterol

31. LACY BE, Shin AS, Cangemi DJ, Yang Y, et al
    Tenapanor is associated with earlier and sustained symptom relief in IBS-C: a post hoc analysis.
    Therap Adv Gastroenterol. 2026;19:17562848251414831.
    

    >> Share

    
    

    
    Transl Psychiatry

32. ZHOU Y, Liu S, Xie S, Zhang Q, et al
    Long-term risk of irritable bowel syndrome associated with adverse childhood and adulthood experiences: a large-scale prospective cohort study.
    Transl Psychiatry. 2026 Jan 28. doi: 10.1038/s41398-026-03833.
    

    >> Share

    
    

    
    Trop Med Int Health

33. BADWEI N, Abdelsalam A, Wassif GO, El-Din HES, et al
    Quality of Life and Psychological Burden in Irritable Bowel Syndrome: The Impact of Intestinal Parasitic Infections (Phase II Study).
    Trop Med Int Health. 2026 Jan 23. doi: 10.1111/tmi.70079.
    

    >> Share

    
    

    
    World J Gastrointest Endosc

34. UPPALA PK, Karanam SK, Maddi R
    Science of fecal microbiota transplant: From history to cutting-edge clinical practice.
    World J Gastrointest Endosc. 2026;18:113133.
    

    >> Share

    
    

Free Medical Abstracts
Privacy Policy
Sponsors
Share